Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

AbbVie Inc (NYSE: ABBV) said on Tuesday that its Board of Directors had appointed Robert A. Michael, the company’s current President and Chief Operating Officer, to the role of Chief Executive Officer.

Michael is to succeed Richard A. Gonzalez, who has been CEO since the company’s foundation in 2013.

Gonzalez will become Executive Chairman of the Board of Directors, effective July 1st.

Michael has also been appointed as a member of the Board, effective July 1st.

”On behalf of AbbVie’s board, I am extremely excited that Rob has agreed to serve as AbbVie’s next CEO. As a key member of the Executive Leadership Team, he has had a tremendous impact on AbbVie. From establishing our financial planning organization, to the development of our diversified business strategy, to successfully navigating the end of exclusivity for Humira in the U.S., Rob has been integral to AbbVie’s impact since inception,” Richard A. Gonzalez said in a press release.

“Rob has also played an important role in key business development opportunities that have been critical to delivering on our long-term growth strategy, including the acquisitions of Allergan and ImmunoGen and the pending Cerevel Therapeutics transaction. I have known and worked with Rob for many years, and he has the experience, leadership capabilities and strategic vision to accelerate AbbVie’s success well into the future,” Gonzalez said.

”The business is performing very well and is in a strong position for the long term. Our pipeline contains multiple promising candidates to sustain our future strong growth. It has been a privilege and immensely gratifying to serve with all my AbbVie colleagues for the past 11 years growing AbbVie into what it is today, and I look forward to continuing to work with Rob as executive chairman of the board,” Gonzalez added.

Stock Performance

The shares of AbbVie Inc (ABBV) closed 0.98% ($1.74) lower at $175.75 in New York on Tuesday. Last Friday, the stock rose as high as $178.92 – a fresh all-time high.

The company’s total market cap now stands at $310.294 billion.

The shares of AbbVie Inc (ABBV) went down 4.11% in 2023, compared with a 24.23% gain for the benchmark index, S&P 500 (SPX).

The company’s shares have risen 13.41% so far this year.

Analyst stock price forecast and recommendation

According to TipRanks, at least 12 out of 18 surveyed investment analysts had rated AbbVie Inc’s stock as “Buy”, while 6 – as “Hold”. The median price target on the stock stands at $179.00, which translates into a 1.85% upside compared to the closing price on Tuesday.

The high point of the analyst forecast range stands at $200.00.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Forex Market: EUR/SEK daily forecastForex Market: EUR/SEK daily forecast During Friday’s trading session EUR/SEK traded within the range of 8.9978-9.0654 and closed at 9.0585.At 6:15 GMT today EUR/SEK was losing 0.07% for the day to trade at 9.0526. The pair touched a daily low at 9.0474 at 5:45 […]
  • Natural gas trading outlook: futures drop after edging above $4Natural gas trading outlook: futures drop after edging above $4 Natural gas futures failed to maintain above $4 yesterday, though the blue fuel logged an impressive 5% rally since Monday. Investors eye how a cool Canadian weather system plays out in the US, as massive natgas inventory builds are back on […]
  • Gold hits 2-1/2-week low as U.S. service sector growth exceeds projectionsGold hits 2-1/2-week low as U.S. service sector growth exceeds projections Gold fell to the lowest since October 17 after the Institute for Supply Management reported that the U.S. service sector growth quickened in October from a month earlier, confounding analysts expectations for a slower expansion. The report […]
  • Grain futures higher, soybeans touch 10-week highs on increased demand for US suppliesGrain futures higher, soybeans touch 10-week highs on increased demand for US supplies Grain futures were mixed on Monday with soybeans reaching a 10-week high on increased demand for US supplies, while corn and wheat posted moderate losses.On the Chicago Board of Trade, soybeans futures for settlement in January traded at […]
  • Forex Market: EUR/USD daily trading forecastForex Market: EUR/USD daily trading forecast Yesterday’s trade saw EUR/USD within the range of 1.1192-1.1285. The pair closed at 1.1249, ticking up 0.04% on a daily basis, while extending gains from Monday. The daily high has been the highest level since September 24th, when the cross […]
  • Forex Market: USD/RUB daily trading forecastForex Market: USD/RUB daily trading forecast Friday’s trade saw USD/RUB within the range of 35.884-36.290. The pair closed at 36.115, gaining 0.22% on a daily basis.At 7:41 GMT today USD/RUB was down 0.18% for the day to trade at 36.048. The pair touched a daily low at 35.930 at 5:55 […]